{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:28:13Z","timestamp":1786739293927,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"\n Background and Aim:<\/jats:title>\n Seborrheic dermatitis is a common inflammatory disease for which various treatments have been proposed. The main purpose of this study was to determine the effectiveness of 80-mg Triamcinolone solution diluted with 0.1% normal saline for the treatment of seborrheic dermatitis in adults.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n For this study, 120 patients with seborrheic dermatitis were considered. After obtaining written and informed consent, patients were treated with 80 mg of Triamcinolone diluted with 0.1% normal saline. To evaluate the effectiveness of Triamcinolone treatment, the scoring index (SI) and the level of patient satisfaction were evaluated at 2 and 4 weeks after the start of treatment and also 4 weeks after the end of treatment.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The results of the study showed that 61.67% (74 patients) were satisfied with \u201cgood\u201d to \u201cvery good\u201d for the Triamcinolone treatment to seborrheic dermatitis. Based on the findings of the study, it was found that the SI before treatment was equal to 2.45 \u00b1 7.45, which after 2 weeks after treatment, this index decreased by 61.6% (SI: 2.86 \u00b1 1.94). In addition, the SI decreased to 88.6% (SI: 0.85 \u00b1 1.02) after 4 weeks.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Considering the high decrease in SI, increasing patient satisfaction and observing a low number of cases with recurrence of the disease by Triamcinolone treatment method, it can be concluded that injection of Triamcinolone 80 mg diluted with 0.1% normal saline can be effective and efficient for the treatment of seborrheic dermatitis.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_923_22","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T03:51:56Z","timestamp":1675050716000},"page":"7814-7817","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the effectiveness of triamcinolone solution diluted with normal saline for the treatment of seborrheic dermatitis"],"prefix":"10.4103","volume":"11","author":[{"given":"Fatemeh","family":"Jamali","sequence":"first","affiliation":[{"name":"General Physician, Aesthetic Field, Qazvin, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyal","family":"Daneshdoust","sequence":"additional","affiliation":[{"name":"Department of Dermatology, School of Medicine, Babol University of Medical Sciences, Babol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"R1-20260204","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/exd.14450","article-title":"Skin microbiome alterations in seborrheic dermatitis and dandruff: A systematic review","volume":"30","author":"Tao","year":"2021","journal-title":"Exp Dermatol"},{"key":"R2-20260204","first-page":"1","article-title":"Seborrheic dermatitis in older adults: Pathogenesis and treatment options","volume":"8","author":"Sowell","year":"2022","journal-title":"Drugs Aging"},{"key":"R3-20260204","first-page":"e01169","article-title":"Presence of Malassezia hyphae is correlated with pathogenesis of seborrheic dermatitis","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1439-0507.2008.01624.x","article-title":"Quality of life in patients suffering from seborrheic dermatitis: Influence of age, gender and education level","volume":"52","author":"Szepietowski","year":"2009","journal-title":"Mycoses"},{"key":"R5-20260204","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.14984","article-title":"Investigation of the relationship between inflammatory blood parameters and seborrheic dermatitis","author":"Tosun","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/exd.14091","article-title":"An update on the microbiology, immunology and genetics of seborrheic dermatitis","volume":"29","author":"Adalsteinsson","year":"2020","journal-title":"Exp Dermatol"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00449-020-02333-5","article-title":"Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis","volume":"44","author":"Lin","year":"2021","journal-title":"Bioprocess Biosystems Eng"},{"key":"R8-20260204","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/1523-1747.ep12506384","article-title":"Dimorphism of pityrosporum orriculare in a defined culture medium","volume":"69","author":"Dorn","year":"1977","journal-title":"J Invest Dermatol"},{"key":"R9-20260204","first-page":"125","article-title":"Facial seborrheic dermatitis: A report on current status and therapeutic horizons","volume":"8","author":"Bikowski","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMcp0806464","article-title":"Seborrheic dermatitis","volume":"360","author":"Naldi","year":"2009","journal-title":"N Engl J Med"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.2011.10269.x","article-title":"Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: A randomized, controlled study","volume":"165","author":"Ortonne","year":"2011","journal-title":"Br J Dermatol"},{"key":"R13-20260204","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-4362.2003.01981.x","article-title":"Is topical metronidazole effective in seborrheic dermatitis? A double-blind study","volume":"42","author":"Koca","year":"2003","journal-title":"Int J Dermatol"},{"key":"R14-20260204","first-page":"25","article-title":"Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"R15-20260204","doi-asserted-by":"crossref","first-page":"67","DOI":"10.29252\/ajcm.26.2.67","article-title":"Comparison of efficacy of clotrimazole 1% cream with sertaconazole 2% cream in treatment of adult seborrheic dermatitis","volume":"26","author":"Alirezaei","year":"2019","journal-title":"Avicenna J Clin Med"},{"key":"R16-20260204","first-page":"703","article-title":"Treatment of seborrheic dermatitis, comparison of sertaconazole 2% cream versus ketoconazole 2% cream","volume":"182","author":"Lotti","year":"2013","journal-title":"J Dermatol Treat"},{"key":"R17-20260204","first-page":"477","article-title":"Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trial","volume":"18","author":"Attarzadeh","year":"2013","journal-title":"J Res Med Sci"},{"key":"R18-20260204","first-page":"119","article-title":"Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"R19-20260204","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3109\/09546634.2013.782384","article-title":"Comparison of sertaconazole 2% cream versus hydrocortisone 1% ointment in the treatment of atopic dermatitis","volume":"24","author":"Saki","year":"2013","journal-title":"J Dermatol Treat"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijwd.2016.11.008","article-title":"Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial","volume":"3","author":"Balighi","year":"2017","journal-title":"Int J Women's Dermatol"},{"key":"R21-20260204","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008138.pub2","article-title":"Topical antifungals for seborrhoeic dermatitis","author":"Okokon","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_923_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:27:40Z","timestamp":1786735660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_923_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_923_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"2022-04-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}